Skip to main content

Table 1 Patient characteristics at baseline

From: Omalizumab for chronic urticaria in Latin America

Characteristic
Mean age, years (range) 47.8 (18–81)
Sex: female, n (%) 15 (57.7)
Mean duration of CU, months (range) 23.3 (2–180)
Mean IgE, kU/L (range) 570.6 (55–2500)
Differential diagnosis of thyroid disease, n (%) 10 (38.5)
Comorbidities, n (%) 6 (23.1)
Previous medication, n (%) 26 (100)
-First-generation antihistamines alone 5 (19.2)
-Second-generation antihistamines alone 6 (23.1)
-First-generation antihistamines plus corticosteroids 3 (11.5)
-Second-generation antihistamines plus corticosteroids 11 (42.3)
-First- and second-generation antihistamines 1 (3.8)
  1. CU chronic urticaria, IgE immunoglobulin E